Soluble endoglin concentration in maternal blood as a diagnostic biomarker of preeclampsia: a systematic review and meta-analysis

Preeclampsia

(2019) Sarosh Rana et al.   CIRCULATION RESEARCH

The International Federation of Gynecology and Obstetrics ( FIGO ) initiative on pre‐eclampsia: A pragmatic guide for first‐trimester screening and prevention

(2019) Liona C. Poon et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Three risk of bias tools lead to opposite conclusions in observational research synthesis

(2018) Josep-Maria Losilla et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

ACOG Committee Opinion No. 743

(2018)   OBSTETRICS AND GYNECOLOGY

Preeclampsia in 2018: Revisiting Concepts, Physiopathology, and Prediction

(2018) J. Mayrink et al.   TheScientificWorldJOURNAL

Pre-eclampsia: its pathogenesis and pathophysiolgy

(2016) P Gathiram et al.   Cardiovascular Journal of Africa

Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines

(2016) E. Phipps et al.   Clinical Journal of the American Society of Nephrology

An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia

(2016) Numan Cim et al.   Journal of Maternal-Fetal & Neonatal Medicine

Pre-eclampsia

(2016) Ben W J Mol et al.   LANCET

Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia

(2016) Carmen Rădulescu et al.   MEDIATORS OF INFLAMMATION

Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia

(2016) Harald Zeisler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Angiogenic factors and uterine Doppler velocimetry in early- and late-onset preeclampsia

(2014) Clarissa M. Tobinaga et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis

(2014) Rebecca E. Allen et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease

(2013) Sarka Lisonkova et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population?

(2013) L Myatt et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Membrane and Soluble Forms of Endoglin in Preeclampsia

(2013) B. Oujo et al.   CURRENT MOLECULAR MEDICINE

Preeclampsia: a link between trophoblast dysregulation and an antiangiogenic state

(2013) Roberto Romero et al.   JOURNAL OF CLINICAL INVESTIGATION

Review: The enigmatic role of endoglin in the placenta

(2013) A.L. Gregory et al.   PLACENTA

Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis

(2012) CE Kleinrouweler et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Angiogenic imbalance and plasma lipid alterations in women with preeclampsia from a developing country

(2012) L. M. Reyes et al.   GROWTH FACTORS

Comparison of angiogenic and anti-angiogenic factors in maternal and umbilical cord blood in early- and late-onset pre-eclampsia

(2012) Selda Demircan Sezer et al.   GYNECOLOGICAL ENDOCRINOLOGY

Second trimester anti-angiogenic proteins and preeclampsia

(2012) Catherine L. Haggerty et al.   Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health

GRADE guidelines: 3. Rating the quality of evidence

(2011) Howard Balshem et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Increased plasma soluble fms-like tyrosine kinase 1 and endoglin levels in pregnancies complicated with preeclampsia

(2009) Peter Chedraui et al.   Journal of Maternal-Fetal & Neonatal Medicine

Soluble endoglin and transforming growth factor-β1 in women who subsequently developed preeclampsia

(2009) Ji Hyae Lim et al.   PRENATAL DIAGNOSIS

The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia

(2009) Young Nam Kim et al.   PRENATAL DIAGNOSIS

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia

(2008) Antonio De Vivo et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia

(2008) Marc U. Baumann et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion

(2008) Holger Stepan et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Blood pressure augmentation and maternal circulating concentrations of angiogenic factors at delivery in preeclamptic and uncomplicated pregnancies

(2008) Rebecca Troisi et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Endoglin in angiogenesis and vascular diseases

(2008) Peter ten Dijke et al.   ANGIOGENESIS

Circulating and Placental Endoglin Concentrations in Pregnancies Complicated by Intrauterine Growth Restriction and Preeclampsia

(2008) A JEYABALAN et al.   PLACENTA

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal